A Phase I Study of Evaluating Pharmacokinetics, Safety and Preliminary Efficacy Between Treatment with Endostatin 4 Hours Intravenous Infusion and 72 Hours or 168 Hours Intravenous Pump Infusion in Patients with Advanced Non-Small Cell Lung Cancer
crossref（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined